(Part 4 of 4) More Than One Problem: Mental Illness as a Contributing Factor of Pain and Substance Use in People With HIV
Overview Assessment of Needs Mental illness encompasses a large array of syndromes from mood disorders to thought disorders to personality disorders, which can directly impact pain and substance use. This talk will provide a general overview of the interrelated aspects of mental illness, pain, and substance use among people with HIV (PWH). Additionally, this talk (more…)
HIV Drug Resistance: The 4th Decade
Overview Assessment of Needs The IAS–USA offers this state-of-the-art activity on the evolving challenges of managing HIV disease as part of a nationwide continuing medical education (CME) effort for physicians. Antiretroviral therapy has dramatically reduced the morbidity and mortality associated with HIV infection. The emergence of drug resistance had limited the effectiveness of many (more…)
Update on COVID-19 Vaccines
Program Description The COVID-19 pandemic has created an urgent need for reliable scientific information. Our understanding of SARS-CoV-2 and COVID-19 disease changes almost daily. Unfortunately, there are also misunderstandings, miscommunications, and controversies. In response, the IAS−USA has created a program that will bring together leading experts to discuss the latest science regarding COVID-19 and what (more…)
Managing Gonorrhea and Its Complications: A Case-Based Approach
Overview Assessment of Needs The IAS–USA offers this state-of-the-art activity as part of a nationwide continuing education effort for physicians. The rates of gonorrhea continue to increase in the United States as does the extent of gonococcal antimicrobial resistance. In this webinar, we will consider the epidemiology of Neisseria gonorrhoeae, including the re-emergence of disseminated (more…)
Optimization of Antiretroviral Therapy
Overview Assessment of Needs The IAS–USA offers this state-of-the-art activity as part of a nationwide continuing education effort for physicians on the evolving challenges of managing HIV disease. This webinar will discuss the goals of antiretroviral therapy in people living with HIV who are currently in care and are successfully treated. Further, this webinar will (more…)
Update on SARS-CoV-2 Variants, the Status of Vaccine Development, and Decreasing the Case Rate–What Does it Mean?
Program Description The IAS–USA COVID-19 Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of the disease and the consequences of the pandemic. The Dialogues are intended for healthcare clinicians and researchers. This dialogue will be a continued discussion of (more…)
COVID-19: What We Know Today
Program Description The IAS–USA COVID-19 Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of the disease and the consequences of the pandemic. The Dialogues are intended for healthcare clinicians and researchers. Sign Up Note: An announcement will be released (more…)
Hot Topics in HIV Medicine: A Special IAS-USA CME Course
In Memoriam David A. Katzenstein, MD 1952 –2021 This course is dedicated in memory to David A. Katzenstein, MD, who passed away suddenly on Sunday, (more…)
The Latest on “COVID-19 Meets HIV”: Variants, Vaccines, Health Disparities, and Other Fast-Evolving Issues
Program Description The IAS–USA COVID-19 Dialogues bring together leading experts to discuss what the data and research are telling us about the basic science, public health, and clinical aspects of the disease and the consequences of the pandemic. The Dialogues are intended for healthcare clinicians and researchers. Drs Wendy Armstrong and Carlos del Rio, of (more…)
Cases From the Clinic: Managing the Care of Patients Who Are Highly Treatment Experienced With Limited Treatment Options
Overview Assessment of Needs The IAS–USA offers this state-of-the-art activity as part of a nationwide continuing education effort for physicians on the evolving challenges of managing HIV disease. Although more uncommon with contemporary regimens, clinicians may be presented with patients in whom various regimens and drug classes have failed and who are not virally suppressed. (more…)